DoW, Ovarian Cancer, Ovarian Cancer Clinical Trial Academy - Early-Career Investigator Award
Defense Health Agency Contracting Activity - DHACA
Free. Verify your email, then we send one reminder only.
- Posted
- May 4, 2026
- Amount
- Program total $4.2M
- Closes
- Oct 1, 2026 (in 16 days)
Similar opportunities open now
- DoW, Ovarian Cancer, Ovarian Cancer Academy – Early-Career Investigator AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 16 days
- DoW Kidney Cancer, Academy of Kidney Cancer Investigators – Early-Career Scholar AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 13 days
- DoW Ovarian Cancer, Clinical Trial AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 16 days
- Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Not Allowed)OpenNational Institutes of HealthCloses Mar 2029
- DoW, Ovarian Cancer, Investigator-Initiated Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 16 days
Classification and identifiers
- Solicitation number
- HT942526OCRPOCCTAECI
- Assistance listing (CFDA)
- 12.420
Amount
Program total $4.2M
Who can apply
About this opportunity
Summary: Created in FY23, the Ovarian Cancer Clinical Trial Academy (OCCTA) supports the next generation of Early-Career Investigators (ECIs) in clinical trial research to produce effective treatments and cures for ovarian cancer. The OCCTA, through its Leadership, provides for professional and leadership development of the ECIs to include skills and competencies needed to execute clinical trials, providing intensive mentoring, national networking, collaborations, and a peer group for junior clinical trialists. The OCCTA will bring together established investigators (the Academy Dean and Assistant Dean), established Career Guides (mentors), and a group of ECIs/Scholars to conduct successful, highly productive clinical trials in ovarian cancer. Distinctive Features: Research funded under th...